Blatun L A, Vandiaev G K, Vishnevskiĭ V A, Khlebnikov E P, Makarenkova R V
Antibiotiki. 1984 Mar;29(3):228-32.
The clinico-laboratory estimation of brulamycin in the treatment of 50 patients with severe wound infections showed its high efficacy with respect to gram-negative microflora and in particular Ps. aeruginosa (94 per cent of the sensitive strains). Satisfactory into the affection foci and a long-term maintenance of its therapeutic levels in the host allowed one to recommend the antibiotic for the treatment of patients with complicated purulent affections and first of all systemic infections.
对50例严重伤口感染患者使用布鲁拉霉素进行临床实验室评估，结果显示其对革兰氏阴性菌，尤其是铜绿假单胞菌（94%的敏感菌株）具有高效性。该药物能有效进入感染病灶，并在宿主体内长期维持治疗水平，因此推荐将这种抗生素用于治疗复杂性化脓性感染患者，尤其是全身感染患者。
